Skip to main content

Table 1 Participant characteristics for participation in PHQ-9 completion and cognitive interview

From: Cognitive testing of the PHQ-9 for depression screening among pregnant and postpartum women in Kenya

Characteristic

Frequency

Phase 1 PHQ-9 Completion (N = 29)

Phase 2, Cognitive Interview (N = 20)

Age, years

29.7 (26.4–33.7)

29.3 (25.2–33.3)

Any income reported

19 (65.5%)

12 (60.0%)

Education, years

8.0 (8.0–12.0)

10.5 (8.0–12.0)

Literate

29 (100.0%)

20 (100.0%)

Preferred language of PHQ-9

 English

14 (48.3%)

12 (60.0%)

 Kiswahili

15 (51.7%)

8 (40.0%)

 Kikuyu

0 (0.0%)

0 (0.0%)

Preferred language of cognitive interview

 English

NA

0 (0.0%)

 Kiswahili

6 (30.0%)

 Kikuyu

2 (10.0%)

 Mix of two or more languages

12 (60.0%)

Married or in a relationship

27 (93.1%)

20 (100.0%)

Partnership duration, yearsa

1.6 (0.8–6.2)

1.3 (0.5–5.6)

Number of prior children

1 (1–2)

1 (0–2)

Any unprotected sex with current partner in prior month

7 (24.1%)

5 (25.0%)

Any sex with outside partner in prior month

1 (3.5%)

0 (0.0%)

HIV-infected

13 (44.8%)

8 (40.0%)

On ART, participants living with HIV only

13 (100.0%)

8 (100.0%)

On PrEP, HIV-uninfected participants only

14 (87.5%)

12 (100.0%)

Pregnancy status

 1st Trimester

6 (20.7%)

3 (15.0%)

 2nd Trimester

5 (17.2%)

3 (15.0%)

 3rd Trimester

2 (6.9%)

2 (10.0%)

 Postpartum

16 (55.2%)

12 (60.0%)

Frequency of individual PHQ-9 itemsb

 Little interest or pleasure

17 (58.6%)

12 (60.0%)

 Feeling down, depressed, hopeless

16 (55.2%)

11 (55.0%)

 Trouble sleeping too little or too much

21 (72.4%)

14 (70.0%)

 Tired or little energy

15 (51.7%)

11 (55.0%)

 Poor appetite or overeating

18 (62.1%)

14 (70.0%)

 Feeling bad about yourself

7 (24.1%)

6 (30.0%)

 Trouble concentrating

9 (31.0%)

7 (35.0%)

 Moving slowly or feeling restless

7 (24.1%)

6 (30.0%)

 Thoughts of suicide of self-harm

4 (13.8%)

2 (10.0%)

Median PHQ-9 score

5 (3–9)

5 (3–9.5)

PHQ-9 scoring categories

  < 5

11 (37.9%)

8 (40.0%)

 5–14

17 (58.6%)

11 (55.0%)

  > 14

1 (3.5%)

1 (5.0%)

  1. Data are number (%) or median (IQR). PHQ-9 Patient Health Questionnaire 9-item, ART antiretroviral therapy, PrEP pre-exposure prophylaxis
  2. aPartnership duration was assessed by asking all participants when they first had sex with their study partner and calculating the time between first sex with partner and the enrollment date
  3. bEndorsement of each PHQ-9 item reflects symptom experiences in the prior 2 weeks